Analysis of clinicopathological features and prognostic factors for metastatic colorectal cancer by using biomarkers as IHC of MMR, PD-L1 and TIL.

Analysis of clinicopathological features and prognostic factors for metastatic colorectal cancer by using biomarkers as IHC of MMR, PD-L1 and TIL.

碩士 === 國立中興大學 === 生命科學院碩士在職專班 === 107 === The incidence rate of colorectal cancer is raising in Taiwan, and it ranks second of the top 10 cancers. The average survival time of metastatic colorectal cancer is beyond 2 years in current treatment modalities including surgery, chemotherapy and targeted...

Full description

Bibliographic Details
Main Authors:	Ching-Ming Chang, 張景明
Other Authors:	林赫
Format:	Others
Language:	zh-TW
Published:	2019
Online Access:	http://ndltd.ncl.edu.tw/cgi-bin/gs32/gsweb.cgi/login?o=dnclcdr&s=id=%22107NCHU5105043%22.&searchmode=basic

Similar Items

Review of PD-1/PD-L1 Inhibitors in Metastatic dMMR/MSI-H Colorectal Cancer
by: André F. Oliveira, et al.
Published: (2019-05-01)

Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms
by: Mengjie Jiang, et al.
Published: (2017-01-01)

Development and validation of MMR prediction model based on simplified clinicopathological features and serum tumour markers
by: Yinghao Cao, et al.
Published: (2020-11-01)

Immune Checkpoint Inhibitors in pMMR Metastatic Colorectal Cancer: A Tough Challenge
by: Federica Marmorino, et al.
Published: (2020-08-01)

Detection of lung adenocarcinoma with ROS1 rearrangement by IHC, FISH, and RT-PCR and analysis of its clinicopathologic features
by: Cao B, et al.
Published: (2015-12-01)

VEGF Expression in Colorectal Cancer Metastatic Lymph Nodes: Clinicopathological Correlation and Prognostic Significance
by: Inês Mazeda, et al.
Published: (2020-08-01)

Prognostic and Clinicopathological Significance of PD-L1 Expression for Colorectal Cancer: A Meta-analysis
by: RAO Xionghui, et al.
Published: (2019-11-01)

Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers
by: Ambrosini, M., et al.
Published: (2022)

Prognostic and clinicopathological value of PD-L1 in colorectal cancer: a systematic review and meta-analysis
by: Yang L, et al.
Published: (2019-05-01)

Prognostic Significance of CSN2, CD8, and MMR Status-Associated Nomograms in Patients with Colorectal Cancer
by: Bing Zhu, et al.
Published: (2018-10-01)

Clinicopathological analysis of prognostic factors in colorectal carcinoma
by: Aura Jurescu, et al.
Published: (2016-12-01)

Prognostic and clinicopathological insights of phosphodiesterase 9A gene as novel biomarker in human colorectal cancer
by: Tasmina Ferdous Susmi, et al.
Published: (2021-05-01)

Clinicopathological and prognostic significance of PD-L1 expression in colorectal cancer: a systematic review and meta-analysis
by: Zefeng Shen, et al.
Published: (2019-01-01)

The Prognostic and Clinicopathological Roles of PD-L1 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis
by: Yan Li, et al.
Published: (2019-02-01)

Different surgical outcome and follow-up status between dMMR and pMMR colorectal cancer patients who fulfilled with Amsterdam-II criteria
by: Ci-Yuan Sun, et al.
Published: (2020-08-01)

IHC y Tecnologías Móviles. MTA1. Tipos de IHC
Published: (2014)

Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms.
by: Alexander Koenig, et al.
Published: (2017-01-01)

Clinicopathological analysis of PD-L2 expression in colorectal cancer
by: Guo PD, et al.
Published: (2018-11-01)

Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR status
by: Fotios Loupakis, et al.
Published: (2019-11-01)

MMR - Optimalizace cesty, MMR-optimization of the path
by: JANDA, Vilém
Published: (2014)

ALK-rearranged lung cancer in Chinese: a comprehensive assessment of clinicopathology, IHC, FISH and RT-PCR.
by: Yuan Li, et al.
Published: (2013-01-01)

Serum Tumor Markers Combined With Clinicopathological Characteristics for Predicting MMR and KRAS Status in 2279 Chinese Colorectal Cancer Patients: A Retrospective Analysis
by: Ning Zhao, et al.
Published: (2021-06-01)

Clinicopathological and Prognostic Characteristics of RAD51 in Colorectal Cancer
by: Jae-Ho Lee, et al.
Published: (2020-01-01)

Association between clinicopathological features and survival in patients with primary and paired metastatic colorectal cancer and KRAS mutation
by: Pang X, et al.
Published: (2017-05-01)

Clinicopathologic Features and Prognostic Factors in Alpha-Fetoprotein-Producing Colorectal Cancer: Analysis of 78 Cases
by: Yang Feng, et al.
Published: (2018-12-01)

Study of Metastasis in Lymphnode Biopsies with Special Reference to Immunohistochemistry (IHC) in Metastatic Breast Carcinoma
by: Syed Ali Baqher Hussaini, et al.
Published: (2015-03-01)

Clinicopathological and Prognostic Significance of Immunoscore and PD-L1 in Intrahepatic Cholangiocarcinoma
by: Wu H, et al.
Published: (2021-01-01)

Clinicopathological features of colorectal polyps in 2002 and 2012
by: Yoon Jeong Nam, et al.
Published: (2019-01-01)

Comparison of the endocytoscopic and clinicopathologic features of colorectal neoplasms
by: Kenichi Takeda, et al.
Published: (2016-03-01)

Dominantly Inherited Hereditary Nonpolyposis Colorectal Cancer Not Caused by MMR Genes
by: Mariona Terradas, et al.
Published: (2020-06-01)

Prognostic value, clinicopathologic features and diagnostic accuracy of interleukin-8 in colorectal cancer: a meta-analysis.
by: Wenjie Xia, et al.
Published: (2015-01-01)

Adoptive transfer of TILs plus anti-PD1 therapy: An alternative combination therapy for treating metastatic osteosarcoma
by: Chao Wang, et al.
Published: (2020-12-01)

Tumor infiltrating lymphocytes (TILs) as prognostic biomarker in patients with breast cancer
by: C. Denkert
Published: (2021-04-01)

Clinicopathologic features and prognostic factors of malignant eyelid tumors
by: Chang-Jun Wang, et al.
Published: (2013-08-01)

Correlation of clinicopathological outcomes with changes in IHC4 status after NACT in locally advanced breast cancers: do pre-NACT ER/PR status act as better prognosticators?
by: Chatterjee S, et al.
Published: (2015-12-01)

Prognostic role and clinicopathological features of SMAD4 gene mutation in colorectal cancer: a systematic review and meta-analysis
by: Tian Fang, et al.
Published: (2021-07-01)

Clinicopathologic features and treatment efficacy of Chinese patients with BRAF-mutated metastatic colorectal cancer: a retrospective observational study
by: Xicheng Wang, et al.
Published: (2017-10-01)

Intratumoral Cytotoxic T-Lymphocyte Density and PD-L1 Expression Are Prognostic Biomarkers for Patients with Colorectal Cancer
by: Ilknur Calik, et al.
Published: (2019-10-01)

Metabolomic Markers of Colorectal Tumor With Different Clinicopathological Features
by: Zhiping Long, et al.
Published: (2020-06-01)

Clinicopathologic and genetic features of young patients with colorectal cancer
by: Aronson Melyssa, et al.
Published: (2010-05-01)